<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Hygenix Sandbox]]></title><description><![CDATA[Hygenix Sandbox]]></description><link>https://chat-staging.hygenixinc.com/resources</link><generator>RSS for Node</generator><lastBuildDate>Thu, 19 Nov 2026 14:55:52 GMT</lastBuildDate><atom:link href="https://chat-staging.hygenixinc.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[A Smarter Way to Invest and Scale]]></title><description><![CDATA[Pharma and biotech teams struggle with rising capital investment, tight timelines, and complex manufacturing processes. CDMOs now act as true partners by sharing costs and risks and delivering customized, co-invested manufacturing solutions. Why This Matters Rising Costs and Complexity The U.S. CDMO market for active pharmaceutical ingredients reached $25.3 billion in 2024 and may grow to $33.9 billion by 2030, with a healthy 5.1% annual growth rate. Globally, CDMO services topped...]]></description><link>https://chat-staging.hygenixinc.com/post/a-smarter-way-to-invest-and-scale</link><guid isPermaLink="false">6afec53d5f6b0e34891530c3</guid><category><![CDATA[Documentation]]></category><pubDate>Mon, 23 Jun 2025 04:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/b1a4bd_c9c5d2f349274c4fa25f4992c5f0e378~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Gregg Shupe</dc:creator></item><item><title><![CDATA[Why Pharma Projects Fail Before They Start]]></title><description><![CDATA[Skilled labor is in short supply, and project schedules aren’t getting any easier. Teams often have enough people, but too much of their time is spent working around vague specs, poorly sequenced tasks, and unclear handoffs. These issues burn time and introduce delays that better coordination could prevent. Your staff can’t move efficiently if they’re spending hours clarifying requirements, reworking incorrect work, or waiting for missing documentation. These inefficiencies drain productivity...]]></description><link>https://chat-staging.hygenixinc.com/post/why-pharma-projects-fail-before-they-start</link><guid isPermaLink="false">6afec53d5f6b0e34891530c4</guid><category><![CDATA[Documentation]]></category><pubDate>Mon, 02 Jun 2025 04:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/b1a4bd_84116f6579464431bd4334e4812f752b~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Gregg Shupe</dc:creator></item><item><title><![CDATA[FDA’s AI Push]]></title><description><![CDATA[On May 12, 2025, the FDA announced it would expand its use of generative AI across regulatory review processes, including drugs, medical devices, and food safety evaluations (Axios, 2025). This decision builds on a successful pilot program and supports the broader White House initiative to modernize federal agencies with artificial intelligence. This regulatory shift will affect contract manufacturers, pharmaceutical companies, and the equipment and service vendors that support production...]]></description><link>https://chat-staging.hygenixinc.com/post/fda-s-ai-push</link><guid isPermaLink="false">6afec53d5f6b0e34891530c5</guid><category><![CDATA[Documentation]]></category><pubDate>Mon, 19 May 2025 04:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/b1a4bd_de17fe0d7df14a7f9a67546ca70c4aea~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Gregg Shupe</dc:creator></item><item><title><![CDATA[Stay Ahead of Compliance Changes ]]></title><description><![CDATA[FDA updates for 2024–2025 affect pharmaceutical manufacturing, AI-supported regulatory decisions, and drug supply chain security. Manufacturers should assess regulatory readiness, strengthen QMS and documentation, evaluate advanced manufacturing and AI applications, and improve DSCSA tracing and verification. Proactive compliance can reduce risk, support product quality, and help companies adapt efficiently to evolving FDA expectations.]]></description><link>https://chat-staging.hygenixinc.com/post/stay-ahead-of-compliance-changes</link><guid isPermaLink="false">6afec53d5f6b0e34891530c2</guid><category><![CDATA[Documentation]]></category><pubDate>Mon, 10 Feb 2025 05:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/b1a4bd_c889ce243fbc4f5daaca60d52a49127e~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Gregg Shupe</dc:creator></item></channel></rss>